XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020   13,914,731      
Beginning balance at Dec. 31, 2020 $ 79,328,671 $ 1,375 $ 137,249,496 $ (57,125,635) $ (796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net (in shares)   1,750,000      
Issuance of common stock, net 114,087,891 $ 175 114,087,716    
Stock-based compensation, net of forfeitures 406,488   406,488    
Shares issued for exercise/vesting of stock-based compensation awards (in shares)   13,356      
Shares issued for exercise/vesting of stock-based compensation awards 30,452   30,452    
Net loss (6,576,038)     (6,576,038)  
Ending balance (in shares) at Mar. 31, 2021   15,678,087      
Ending balance at Mar. 31, 2021 187,277,464 $ 1,550 251,774,152 (63,701,673) (796,565)
Beginning balance (in shares) at Dec. 31, 2020   13,914,731      
Beginning balance at Dec. 31, 2020 79,328,671 $ 1,375 137,249,496 (57,125,635) (796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity investment gain (loss) in other comprehensive loss (31,288)        
Net loss $ (14,209,010)        
Ending balance (in shares) at Jun. 30, 2021 15,764,533        
Ending balance at Jun. 30, 2021 $ 180,410,711 $ 1,550 252,571,659 (71,334,645) (827,853)
Beginning balance (in shares) at Mar. 31, 2021   15,678,087      
Beginning balance at Mar. 31, 2021 187,277,464 $ 1,550 251,774,152 (63,701,673) (796,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation, net of forfeitures 611,808   611,808    
Shares issued for exercise/vesting of stock-based compensation awards (in shares)   81,446      
Shares issued for exercise/vesting of stock-based compensation awards 185,699   185,699    
Equity investment gain (loss) in other comprehensive loss (31,288)        
Conversion of performance rights (in shares)   5,000      
Foreign currency translation adjustments (31,288)       (31,288)
Net loss $ (7,632,972)     (7,632,972)  
Ending balance (in shares) at Jun. 30, 2021 15,764,533        
Ending balance at Jun. 30, 2021 $ 180,410,711 $ 1,550 252,571,659 (71,334,645) (827,853)
Beginning balance (in shares) at Dec. 31, 2021   15,894,395      
Beginning balance at Dec. 31, 2021 161,784,606 $ 1,589 255,131,836 (92,683,000) (665,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net (in shares)   2,012,500      
Issuance of common stock, net 122,059,476 $ 201 122,059,275    
Stock-based compensation, net of forfeitures (85,908)   (85,908)    
Shares issued for exercise/vesting of stock-based compensation awards (in shares)   22,631      
Shares issued for exercise/vesting of stock-based compensation awards   $ 3 (3)    
Equity investment gain (loss) in other comprehensive loss 193,644       193,644
Net loss (9,154,632)     (9,154,632)  
Ending balance (in shares) at Mar. 31, 2022   17,929,526      
Ending balance at Mar. 31, 2022 274,797,186 $ 1,793 377,105,200 (101,837,632) (472,175)
Beginning balance (in shares) at Dec. 31, 2021   15,894,395      
Beginning balance at Dec. 31, 2021 161,784,606 $ 1,589 255,131,836 (92,683,000) (665,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity investment gain (loss) in other comprehensive loss (149,123)        
Net loss (18,735,935)        
Ending balance (in shares) at Jun. 30, 2022   17,964,863      
Ending balance at Jun. 30, 2022 266,557,673 $ 1,796 378,789,754 (111,418,935) (814,942)
Beginning balance (in shares) at Mar. 31, 2022   17,929,526      
Beginning balance at Mar. 31, 2022 274,797,186 $ 1,793 377,105,200 (101,837,632) (472,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation, net of forfeitures 1,591,231   1,591,231    
Shares issued for exercise/vesting of stock-based compensation awards (in shares)   35,337      
Shares issued for exercise/vesting of stock-based compensation awards 93,326 $ 3 93,323    
Equity investment gain (loss) in other comprehensive loss (342,767)       (342,767)
Net loss (9,581,303)     (9,581,303)  
Ending balance (in shares) at Jun. 30, 2022   17,964,863      
Ending balance at Jun. 30, 2022 $ 266,557,673 $ 1,796 $ 378,789,754 $ (111,418,935) $ (814,942)